Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)

Despite intensive research, therapy of diabetes mellitus type 2 (T2DM) is far from be effective. The most important unresolved issue is to establish a safe glycosylated hemoglobin C (A1c) value well balanced between benefit and side effects. As a result different guidelines suggest different A1c tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggi, Davide, Montecucco, Fabrizio, Adami, Gianfranco, Cordera, Renzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585025/
https://www.ncbi.nlm.nih.gov/pubmed/31249634
http://dx.doi.org/10.1186/s13098-019-0442-x
_version_ 1783428622434959360
author Maggi, Davide
Montecucco, Fabrizio
Adami, Gianfranco
Cordera, Renzo
author_facet Maggi, Davide
Montecucco, Fabrizio
Adami, Gianfranco
Cordera, Renzo
author_sort Maggi, Davide
collection PubMed
description Despite intensive research, therapy of diabetes mellitus type 2 (T2DM) is far from be effective. The most important unresolved issue is to establish a safe glycosylated hemoglobin C (A1c) value well balanced between benefit and side effects. As a result different guidelines suggest different A1c targets generating confusion for patients and clinicians. Here we report two observations which might support a relaxed A1c as suggested by American college of physician (ACP).
format Online
Article
Text
id pubmed-6585025
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65850252019-06-27 Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently) Maggi, Davide Montecucco, Fabrizio Adami, Gianfranco Cordera, Renzo Diabetol Metab Syndr Commentary Despite intensive research, therapy of diabetes mellitus type 2 (T2DM) is far from be effective. The most important unresolved issue is to establish a safe glycosylated hemoglobin C (A1c) value well balanced between benefit and side effects. As a result different guidelines suggest different A1c targets generating confusion for patients and clinicians. Here we report two observations which might support a relaxed A1c as suggested by American college of physician (ACP). BioMed Central 2019-06-20 /pmc/articles/PMC6585025/ /pubmed/31249634 http://dx.doi.org/10.1186/s13098-019-0442-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Maggi, Davide
Montecucco, Fabrizio
Adami, Gianfranco
Cordera, Renzo
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title_full Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title_fullStr Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title_full_unstemmed Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title_short Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
title_sort glycosylated haemoglobin (a1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585025/
https://www.ncbi.nlm.nih.gov/pubmed/31249634
http://dx.doi.org/10.1186/s13098-019-0442-x
work_keys_str_mv AT maggidavide glycosylatedhaemoglobina1cbestvaluesfortype2diabetesinthebattlefieldmuchadoaboutnothingapparently
AT montecuccofabrizio glycosylatedhaemoglobina1cbestvaluesfortype2diabetesinthebattlefieldmuchadoaboutnothingapparently
AT adamigianfranco glycosylatedhaemoglobina1cbestvaluesfortype2diabetesinthebattlefieldmuchadoaboutnothingapparently
AT corderarenzo glycosylatedhaemoglobina1cbestvaluesfortype2diabetesinthebattlefieldmuchadoaboutnothingapparently

Ejemplares similares